Jean-Pierre Garnier
Independent Non-Executive ChairmanDr. Jean-Pierre Garnier, also known as JP, Ph.D., M.B.A., has been an Independent Chairman of the Board of BioAge Labs, Inc. since August 20, 2024. He serves as an Independent Non-Executive Chairman at Cellectis S.A. since November 5, 2020. He serves as an Operating Partner at Advent International Corporation since 2011. Dr. Garnier served as Lead Independent Director of Carrier Global Corporation since 2019. Dr. Garnier has been Independent Director of Carrier Global Corporation (CGC) since 2020. He had been an Executive Director of GlaxoSmithKline PLC since 1992. He had been Chairman of Carmat SA since December 3, 2018 until December 2022. He serves as a Scientific Advisor at KBL Merger Corp. IV. He was a Member of Scientific & Advisory Board at the firm. In 2009, Dr. Garnier was made a Knight Commander of the British Empire and in 2007 was named Officer de la Legion d'Honneur of France. He served as the Chief Executive Officer of GlaxoSmithKline Plc from May 23, 2000 to May 2008 and served as its Chief Accounting Officer since January 2001. He was also a Member of the Board at the firm. He served as the Chief Executive Officer of Pierre Fabre S.A. from October 2008 to September 1, 2010. In 2000, he served as the Chief Executive Officer of SmithKline Beecham Limited and served as its Executive Member of the Board of Directors from 1996 to 2000. He joined SmithKline Beecham in 1990 as the President of its pharmaceutical business in North America and served as its the Chairman of Pharmaceuticals since 1994 until 1995 and served as its the Chief Operating Officer since 1995 and also served as Chief Operating Officer and Executive Member of the Board of Directors, SmithKline Beecham plc from 1996 to 2000. Dr. Garnier served as the President of US business at Schering-Plough Corporation. During his long career at Schering, he held various management positions, including General Manager of several overseas subsidiaries. In 1983, Dr. Garnier joined the US Pharmaceutical Products Division serving as the Vice President of Marketing. He was then named Senior Vice President and General Manager of the OTC business and assumed responsibility for sales and marketing for the U.S. prescription business prior to becoming President. He had been Chairman at Idorsia Ltd (Biopharmaceuticals) since 2018 until May 13, 2020. He served as the Chairman and Director of Alzheon, Inc. since December 10, 2015 until November 2018. He served as Chairman at NormOxys, Inc. from 2010 to 2011. He served as the Chairman of Actelion Ltd since September 27, 2011 until June 16, 2017. He had been Director of Radius Health, Inc. since December 2015 until August 10, 2022. Dr. Garnier served as a Member of Advisory Board of Dubai International Capital L.L.C. Dr. Garnier serves as a Member of Advisory Board of Quaker Partner. He had been an Independent Director of Raytheon Technologies Corporation (formerly known as United Technologies Corporation) since 1997 until 2020. since May 5, 2011. He serves on the Boards of Directors at the Eisenhower Exchange Fellowships Inc. and on the Advisory Board of Quaker BioVentures. Dr. Garnier also serves on the Stanford University Advisory Council on Interdisciplinary Biosciences. He is a Member of the Board of trustees of Newman's Own Foundation, a former Member of the Stanford Advisory Council on Interdisciplinary Biosciences, the Board of Overseers of Weill Cornell Medical College and a Trustee of The Max Planck Institute from 2013 to 2019. He served as Chairman and Director of Cerenis Therapeutics Holding SA. He served as Vice Chairman at Innovation Philadelphia Inc. Dr. Garnier served as an Independent Director of Renault Société Anonym since April 2008 until April 29, 2016. He served as a Director of Actelion Ltd since May 5, 2011 until June 16, 2017. He served as a Director of INSEAD. In January 1997, he was selected by President Chirac of France to receive the Chevalier de la Légion d'Honneur. In April 1997, Dr. Garnier has been a major figure in the pharmaceutical industry. He received from the Cancer Research Institute the Oliver R Grace Award for Distinguished Service in Advancing Cancer Research. In 2001, he was named one of 50 'Stars of Europe' by BusinessWeek magazine and presented with the Marco Polo Award for GlaxoSmithKline's commitments to China. In 2002, Dr. Garnier received the Humanitarian Award from the Sabin Vaccine Institute and the Legend Lifetime Achievement Award from the Eastern Technology Council. He was promoted from Chevalier to Officier de la Légion d’Honneur of France. In March 2002, he was honoured with the Fulbright Association's Lifetime Achievement Medal. In 2006, he was named to the global list of top 20 Chief Executive Officers by the Best Practice Institute. He is also a Member of the Advisory Board of the Newman’s Own Foundation. His Other Leadership Experience and Service: Board of Trustees, Max Planck Florida Institute for Neuroscience Officer de la Légion d’Honneur of France. He is Member, Advisory Board of Newman’s Own Foundation. He holds a Ph.D. in Pharmacology and an M.S. in Pharmaceutical Science from the University of Louis Pasteur University of Strasbourg, France. As a Fulbright Scholar, Dr. Garnier earned an MBA at Stanford University, California, in 1974.
公司职务
- 公司名称Cellectis S.A.股票代码CLLS职务Independent Non-Executive Chairman共事同僚
- ACAndre ChoulikaCo-Founder, CEO & Director
- DJDavid J. SourdiveCo-Founder, Deputy CEO, Executive VP of CMC & Manufacturing and Director
- ASArthur StrilCFO & Chief Business Officer
- VCValerie CrosPrincipal Financial Officer & Principal Accounting Officer
- JCJean Charles EpinatChief Technological Officer
- ACAndre C. MullerIndependent Director
- LALaurent ArthaudDirector
- 公司名称BioAge Labs, Inc.股票代码BIOA职务Independent Chairman of the Board共事同僚
- KFKristen FortneyCo-Founder, CEO, President, Treasurer, Secretary & Director
- JGJean-Pierre GarnierIndependent Chairman of the Board
- EMEric MorgenCo-Founder, COO & Director
- PDPaul D. RubinChief Medical Officer & Executive VP of Research
- DADov A. GoldsteinChief Financial Officer
- SBShane BartonSenior Vice President of Finance & Accounting
- RHRekha HemrajaniIndependent Director
- JIJames Irvin HealyIndependent Director
